AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
AbbVie and Harvard University today announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and...
Merck’s KEYTRUDA Receives Two New Approvals in Japan
Merck , known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the...
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
Pfizer Inc and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program...
Laurent Pharma Initiates Phase II Trial of LAU-7b in COVID-19 Disease
LAU-7b has shown potent antiviral effects against SARS-CoV-2 and MERS-CoV coronaviruses, and is also being developed for its anti-inflammatory properties.
Laurent Pharmaceuticals Inc., a Montreal-based...
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the first volunteers have been enrolled in the...
CPI Expands Continuous Manufacturing Partner Network
CPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines...
Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic
Q BioMed Inc., a commercial-stage biotech company, said that with its technology partner, Mannin Research, a GMP production contract has been initiated for MAN-19,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...